T1	Participants 514 634	patients with bilaterally symmetrical proliferative diabetic retinopathy or severe nonproliferative diabetic retinopathy
T2	Participants 654 699	patient underwent panretinal photocoagulation
T3	Participants 1809 1835	patient compared with GLX.
